Megan Mantica

Also affiliated with UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma”.

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf079

N/A

0.394DataRank · unranked

9 citations

Andrea G. Manzanera, Caroline Duault, Edgar Gonzalez‐Kozlova, Lenika Lopez, Stuart A. Grossman +50 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

The Oncologist(2025)10.1093/oncolo/oyaf362

N/A

0.307DataRank · unranked

6 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

medRxiv(2025)10.1101/2025.07.19.25331848

N/A

0.279DataRank · unranked

5 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

The interim result of a phase I/II study of nivolumab with or without ipilimumab in combination with multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2068

N/A

0DataRank · unranked

10 citations

Feng Gao, Joshua S. Shimony, Tanner M. Johanns, Megan Mantica, Timothy R. Gershon +6 more

C/EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastoma

Cellular and Molecular Immunology(2025)10.1038/s41423-025-01360-0

N/A

0DataRank · unranked

3 citations

Qinglin Kong, Bhuvitha Chagantipati, Amelia Stepniak, Ambika P. Jaswal, Chaim T. Sneiderman +25 more